< Back to previous page


Therapeutic and Diagnostic Antibodies


Lifecycle:1 Apr 2013 →  Today
Organisation profile:

The research group Therapeutic and Diagnostic Antibodies is active in the field of thrombosis and fibrinolysis with a focus on plasminogen activator inhibitor 1 (PAI-1) and thrombin activatable fibrinolysis inhibitor (TAFI). Diverse panels of monoclonal antibodies, nanobodies and diabodies are being generated and used in in vitro and in vivo research settings as well as for the development of diagnostics and therapeutics.

Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences